Figure S1 2-pyridones on L. monocytogenes infectivity. GFPexpressing L. monocytogenes treated with compound at the indicated concentrations (100 M, black bars; 10 M, white bars) was allowed to infect HeLa cells for 7 hours, before analysis with a flow cytometer. The relative infection is calculated compared to the control (C; DMSO treated L. monocytogenes) (100%, grey bars). Values represent the mean  standard deviation. n = 3. Significance was tested using Student's t-test (two-tailed -significant differences are shown by asterisks; * p<0.05 and *** p<0.001) and Dunnett's test (significant differences to the control are shown by #). (C) Growth of L. monocytogenes EGDe in brain heart infusion (BHI) medium + 0.1% DMSO (C -solvent); BHI + 100 µM 1; 2 or 3, respectively. Growth (n=4) was plotted as growth (OD 600 ) versus time (minutes). Error bars show standard deviation. The difference in growth between strains treated with compounds 1 or 2 compared with DMSO is statistically significant according to Student's t-test. (PrfA G145S ) and ΔprfA, respectively) grown in BHI medium supplemented with DMSO (C) or compounds 1, 2 or 3 at 100 µM. Northern blot analysis was performed and membranes were hybridized with hly, actA, inlA, plcA or tmRNA specific DNA probes. Specific products are indicated at the left of the blots. (B) Relative levels of specific mRNA products identified in (a). All values were divided by the value of the wild-type strain (EGDe (PrfA WT )) treated with DMSO, which was arbitrarily set to 1.0. Error bars show standard deviation. Significance was tested using Dunnett's test (significant differences to the control are shown by #). Values for samples from EGDe (PrfA WT ) treated strains were compared with the value of sample (EGDe (PrfA WT ) treated with DMSO, whereas samples from EGDe (PrfA G145S ) treated strains were compared with the value of sample (EGDe (PrfA G145S ) treated with DMSO. In each case small volumes of compound were injected to a solution of PrfA in the cell. The upper parts of the graphs show the measured heat after every injection, while the lower parts show integrated heat, normalized by amount and after background subtraction, as a function of molar ratio of compound to PrfA. Least-square fitting yields thermodynamic parameters that are given in Table 1 .
A B
Figure S4 showing the electron density quality of 1 bound to monomer B at site BII of the PrfA dimer. The σ A -weighted (2m|Fo|-D|Fc|) electron density map calculated with phases from the refined structure is contoured at one root-mean-square deviation (RMSD) value of the map, and shown in blue. The σ A -weighted (m|Fo|-D|Fc|) electron density, contoured at 3 times the RMSD value is shown in orange. To avoid model bias compound 1 was excluded from the coordinate file that was subjected to one round of refinement before calculation of the |Fo|-|Fc| electron density map. Shown is the electron density covering 1 and selected residues of the binding sites including amino acids A-Leu60-Lys64, A-Leu120-Val124, A-Ile149-Gly155 and A-Leu227-Thr232 at site AI and amino acids A-Phe131-Ser135, B-Asn59-Tyr62, and B-Tyr126-Ser135 at site BII. In both binding sites compound 1 is well defined in the non-biased (m|Fo|-D|Fc|) electron density map. 
Supplemental Experimental Procedures

Chemistry
General
All reagents and solvents were used as received from commercial suppliers. TLC was performed on aluminum backed silica gel plates (median pore size 60 Å) and detected with UV light at 254 nm. Column chromatography was performed using silica gel with average particle diameter 50 µM (range 40-65 µM, pore diameter 53 Å) and eluents are given in brackets.
Optical rotation was measured with a polarimeter at 25 °C at 589 nm. IR spectra were recorded on a spectrometer equipped with an ATR device.
1 H and 13 C NMR spectra were recorded on a 400 MHz spectrometer at 298 K and calibrated by using the residual peak of the solvent as the internal standard (CDCl3: δH = 7.26 ppm; δC = 77.16 ppm; DMSO-d6: δH = 2.50 ppm; δC = 39.50 ppm). HRMS was performed by using a mass spectrometer with ESI-TOF (ESI+); sodium formate was used as the calibration chemical. HPLC purifications were performed on a system equipped with a 250 × 21.5 mm Nucleodur ® C18 HTEC (particle size 5 µM) column using a flow rate of 20 mL/min and detection at 220 nm. Compound 1 was synthesized as described previously (Chorell et al., 2010) .
General procedure for Suzuki-Miyaura cross-couplings
The chloromethyl derivative 6 (1.0 eq.), boronic acid (2.5 eq.), Pd(Ph3P)2Cl2 (0.1 eq.) and KF (2.5 eq.) were dissolved in MeOH (10 mL) and heated by microwave irradiation (MWI) at 110 or 140 °C for 10 min. The reaction mixture was diluted with saturated aqueous NaHCO3 and extracted with ethyl acetate. The organic layer was successively washed with water and brine, dried (Na2SO4) and concentrated under reduced pressure. Purification by flash chromatography (SiO2; EtOAc/heptane; 30-100%) afforded the cross-coupled product.
General methyl ester hydrolysis procedure
Methyl carboxylates 7-10 were hydrolysed by adaption of a previously reported procedure (Chorell et al., 2010) . LiOH (1 M aqueous) was added drop wise to a stirred solution of methyl ester substituted 2-pyridone in THF (30 mL/mmol) at 0 °C. The solution was allowed to attain room temperature and was stirred for 12 h. The mixture was diluted with CH2Cl2 and acidified with aqueous HCl (1 M) to circa pH 1. The separated organic layer was dried (Na2SO4), and concentrated under reduced pressure. The residue was triturated with diethyl ether (3×) and lyophilized (H2O:MeCN; ~ 8:2) to afford the carboxylic acid. 6, 160.1, 156.9, 148.0, 133.7, 133.1, 133.0, 132.2, 127.6, 126.4, 126.3, 126.2, 125.4, 125.1, 113.5, 112.6, 62.8, 55.3, 39.2, 31.5, 20.3, 11.3, 8.0, 7.7 and heated by MWI at 110 °C for 10 min. The reaction mixture was quenched with saturated aqueous NaHCO3 solution (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed successively with saturated aqueous NaHCO3 solution, water (2×) and brine (10 mL each), dried (Na2SO4) and concentrated under reduced pressure. 3, 160.9, 154.3, 152.8, 149.9, 146.8, 135.6, 132.9, 129.9, 129.3, 128.2, 128.1, 127.2, 115.2, 111.9, 66.6, 56.1, 39.1, 31.6, 11.4, 8.4, 7.9 168.7, 161.3, 157.5, 157.0, 148.4, 133.7, 133.0, 132.1, 129.1, 128.8, 127.5, 127.1, 119.2, 115.7, 113.4, 107.8, 62.7, 55.3, 39.3, 31.9, 11.2, 7.9, 7.7 160.4, 157.1, 148.4, 133.7, 133.1, 133.0, 132.1, 127.8, 126.8, 126.5, 126.2, 125.3, 125.1, 113.9, 112.4, 62.8, 35.8, 31.7, 19.6, 11.2, 7.9, 7.7 7, 160.1, 157.0, 156.6, 148.5, 133.6, 133.1, 129.1, 128.7, 127.3, 126.8, 118.8, 114.3, 111.8, 107.8, 62.5, 55.4, 38.3, 31.6, 10.9, 7.9, 7.8 
Methyl (3R)-8-cyclopropyl-7-[(4-methylnaphthalen-1-yl)methyl]-5-oxo-2,3-dihydro-5H
(3R)-8-cyclopropyl-7-(naphthalen-2-ylmethyl)-5-oxo-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyridine-3-carboxylic acid (5)
.
Molecular Biology and Biochemistry
Site directed mutagenesis for PrfA G145S substitution and allelic replacement 10 ng of plasmid pLis35 (Sheehan et al., 1996) was amplified by PCR with a Phusion DNA polymerase (Thermo Scientific) using primers PrfA-G145S-F and PrfA-G145-R and digested overnight with 10U DpnI (Thermo Scientific) according to manufacturer's instructions. E. coli strain DH5α was transformed with a resulting reaction mix, transformants selected for plasmid DNA purification. Correct sequence of prfA gene carrying the G145S substitution was verified by sequencing the insert in the resulting plasmid pKVA609. The prfA G145S allele DNA fragment was excised from pKVA609 with PstI endonuclease, blunted using Mung Bean Nuclease (New England Biolabs) and ligated into SmaI site of the pMAD vector to construct the allelic replacement plasmid pKVA973. The prfA allele replacement with the prfA* was performed using pKVA973 plasmid in L. monocytogenes strains EGDe and Δlmo0866 as described previously (Arnaud et al., 2004) .
Protein Purification
pET28a (prfA) (Sheehan et al., 1996) was introduced into E. coli BL21(DE3) by heat-shocking.
Transformants were grown in LB supplemented with kanamycin and chloramphenicol. At an OD600 of 0.8 the PrfA expression was induced by isopropyl β-D-1-thiogalactopyranoside (IPTG) for 3 h, and the cells were subsequently lysed by sonication. PrfA was extracted by Ni-NTA Superflow FF (Qiagen), followed by thrombin (GE-Healthcare) cleavage and dialyzed against buffer (200 mM NaCl, 10 mM Tris pH 7.5, 1 mM dithiothreitol (DTT)) at 4C overnight. The thrombin cleaved protein had an N-terminal tail of residues GSHMASMTGGQQMGRGS followed by residues Glu7-N237. The protein was purified by MonoS 5/5 ion-exchange (GEHealthcare). The column was eluted with a lineal gradient of 200-1000 mM NaCl, and the pure protein eluted at ~250 mM NaCl, 10 mM Tris pH 7.5, 1 mM DTT. The peak fractions of PrfAWT were pooled and concentrated using a Centriprep-10 centrifugal concentrator (Millipore) to a final concentration of 3.5 mg ml -1 .
Western blot
Overnight cultures of L. monocytogenes were diluted to an OD600 of 0.025 in BHI supplemented with DMSO, or the ring-fused 2-pyridone compounds dissolved in DMSO, resulting in a final concentration of 0.1% DMSO. The cultures were grown at 37 °C to an OD600 of 1.0. The supernatants and bacterial pellets were collected for protein precipitation and treated as follows:
LLO and P60 Western blotting detection: 1 ml of the culture supernatant was filtered through 0.22 µm PVDF filter (Millipore) and subjected to trichloroacetic acid (TCA) precipitation.
1/100 vol 2% sodium deoxycholate (Sigma Aldrich) was added to the samples and incubated at RT for 10 min. One fourth volume of ice cold 50% TCA was added to the samples and incubated on ice for 1 h. The samples were spun down (10 min, 18,000 rcf) and the precipitate washed in 80% ice cold acetone. The dried protein pellets were suspended in 1  sample buffer (Laemmli, 1970 ) and subjected to SDS-PAGE and Western blotting using rabbit anti-LLO 
ActA western blotting detection for intracellular bacteria:
The collected bacterial pellets were resuspended in 100µl 1x sample buffer (Laemmli, 1970) and lysed by incubation at 98 C for 20 min. 10µL of each sample was subjected to SDS-PAG and Western blotting using anti-ActA and HRP conjugated secondary antibodies (#as09602, Agrisera).
Antibody production
Production of antibodies against ActA was conducted by Agrisera. The antibodies were raised in rabbits, against a peptide mix consisting of Y21T (Kocks et al., 1993) and (NH2-) CKDAGKWVRDKIDENPE (-CONH2). The rabbits were immunized four times over a four month period, the first with FCA and the subsequent with FIA. The antisera was recovered 2 weeks after the last immunization.
Infection for determination of intracellular ActA levels
Caco-2 cells were seeded into 24 well plates (Corning #356408) and allowed to grow until confluent. Indicated bacterial strains were grown to OD600 = 1, added to CaCo-2 cells at a MOI of 10, centrifuged for 10 min at 800 g and allowed to infect for 30 minutes. After washing, 1ml
DMEM supplemented with 100µM of 2 and 50µg/ml of gentamicin was added. For extraction of intracellular bacteria, the cells were first washed in PBS, and then lysed using PBS supplemented with 1% Triton X-100. The cell lysate was transferred to Eppendorf tubes, and centrifuged at 20238 g for 1 min. The supernatant was removed and the pellets stored at -20 C before western blot analysis.
Hemolytic activity assay
Goat erythrocytes (Agrisera) were diluted to 10% in PBS pH 7.4. Overnight cultures of L.
monocytogenes were diluted to an OD600 of 0.005 in BHI adjusted to pH 5.5 with HCl, supplemented with 0.3 M NaCl and DMSO or compounds dissolved in DMSO, resulting in a final concentration of 0.1% DMSO. The cultures were subsequently grown at 37 C to an OD600 of 1.0. The supernatants were filtered through 0.22 µm PVDF filters (Millipore) and aliquoted in 96 well plates in triplicate. 10% erythrocyte solution was subsequently added to a final concentration of 5%. The samples were stored at 37 C for 3 h, spun down and 100 l of the supernatant measured at an optical density at 541 nm using a TECAN Infinite M200 plate reader. Samples were done with four replicates.
Northern blot
Northern blotting was performed as described previously (Tiensuu et al., 2013) . In brief, 20 g of RNA was separated on an agarose gel (1.2% agarose, 1  HEPES buffer (20 mM HEPES, 5 mM NaAc, 1 mM EDTA, adjusted to pH 7), 7.3% formaldehyde). The gel was run in 1× HEPES buffer at 100 V for 4 h and the RNA was transferred to a Hybond-N membrane (Amersham/GElifesciences) by capillary transfer in 20 × SSC buffer. The membranes were cross-linked by UV-light, pre-hybridized at 60 °C in Rapid hyb buffer (Amersham/GE-lifesciences) for about 2 h and then hybridized with DNA probes at 60 °C overnight. Membranes were washed (0.5% SDS, 2 × SSC, room temperature for 15 min followed by 0.5% SDS, 0.1 × SSC 60 °C for 15 min), exposed in a phosphorimager cassette and developed using the Typhoon FLA9500 Scanner (HE Lifesciences). The probes were created by amplifying genomic L. monocytogenes
EGDe DNA by PCR using primers BM1/BM2 for hly; actA-qF/actA-qR for actA; inlA-U/inlD for inlA and inlAB; plcA-U/plcA-D for plcA and plcA-prfA and tmRNA-U/tmRNA-D for tmRNA. Sequences of primers are found below. Probes were subsequently labeled with -32P dATP (PerkinElmer) using Megaprime DNA labelling system (Amersham/GE-lifesciences), according to the manufacturer's instructions.
Surface plasmon resonance (SPR)
SPR experiments was conducted in a Biacore X100 (Biacore/GE Healthcare), and performed mainly as described previously (Deshayes et al., 2012) . In brief, biotinylated oligonucleotides 
Isothermal titration calorimetry (ITC)
ITC experiments were performed using a MicroCal AutoiTC200. In a typical run, 25 automated injections of 1.65 µl with 170 s breaks in between injections were made at 25 °C with 600 rpm stirring speed on low feedback mode. The protein concentrations in the cell were varied between 25 and 100 µM while the compound concentration in the syringe was varied from 300 to 800 µM. The buffer for both protein and compound solutions was the same as in the final step of the purification. The compounds were dissolved in DMSO, and then diluted with buffer.
DMSO content in the final compound solutions did not exceed 0.5% (v/v). Data integration, fitting and evaluation were performed using the software Origin™ 7 with the ITC200 plugin provided by MicroCal/GE Healthcare.
Crystallography
Crystallization
Using 5' NcoI and 3' Acc651 restriction sites, the PrfA gene was cloned into a modified pET24d plasmid containing an upstream, in frame coding region for a 6-His tag and a Tobacco etch virus (TEV) protease cleavage site. The construct was transformed into the expression strain E.
coli BL21 (DE3) pLysS (Novagen). The PrfA protein was expressed in E. coli as described above (Protein purification). Following cell lysis, the protein was extracted from the soluble fraction by Ni-NTA Superflow FF (Qiagen), followed by TEV protease cleavage and was dialyzed at 4C overnight against buffer (200 mM NaCl, 20 mM NaP (NaH2PO4+Na2HPO4) buffer pH 7.1, and 1 mM dithiothreitol (DTT)). The TEV cleaved protein contains two nonnative N-terminal residues GA followed by the native residues M1-N237. The protein was purified by Ni-NTA Superflow FF (Qiagen) followed by MonoS 10/10 ion-exchange (GEHealthcare) and Superdex 75 16/60 size exclusion chromatography (GE-Healthcare). The
MonoS column was eluted with a linear salt gradient between 100-1000 mM NaCl. The pure protein eluted at about 200 mM NaCl, 20 mM NaP, pH 6.5. Size exclusion chromatography was performed with the same buffer (200 mM NaCl and 20 mM NaP buffer pH 6.5). The peak fractions of PrfAWT were pooled and concentrated using a Centriprep-10 centrifugal concentrator (Millipore) to a final concentration of 3.5 mg ml -1 .
percent of the observed structure factors were not included in the refinement and were instead used for validation by free R-factor calculations. The refined structure comprises residues 2-237 of both monomers, two 1 molecules, and 22 water molecules that are well-defined in the electron density. 98% of all residues were in Ramachandran favored region, and 0% were Ramachandran outliers. Not modeled in the structure are the flexible residues 176-182 (similar to the 2beo structure). Weak electron density is also observed for one loop regions including Refinement statistics are summarized in Table 2 . 
